What the Iran War Means for Pharma Supply Chains - Report - MDSpire
Advertisement
What the Iran War Means for Pharma Supply Chains
Argon & Co’s Michel Savini discusses the medicines most exposed to geopolitical instability, and why scenario planning remains underused across life sciences
Clinical Report: What the Iran War Means for Pharma Supply Chains
Overview
Pharmaceutical supply chains face increased pressure due to geopolitical instability, particularly from the Iran conflict, which compounds existing challenges from the Ukraine war and rising raw material costs. Only 22% of life sciences firms are preparing for disruptions, despite significant operational pressures.
Background
The vulnerability of pharmaceutical supply chains has been highlighted by recent geopolitical events, including the pandemic and conflicts in Ukraine and the Middle East. These disruptions have exposed the fragility of global networks, particularly concerning active pharmaceutical ingredients (APIs) and cold chain logistics.
Data Highlights
Argon & Co’s Operations Outlook 2026 report indicates that 62% of life sciences leaders report pressure to reduce operational costs, while 40% cite rising raw material costs as their biggest supply chain challenge.
Key Findings
Only 22% of pharmaceutical firms are actively preparing for supply chain disruptions.
62% of life sciences leaders face pressure to reduce operational costs.
40% of firms identify rising raw material costs as a significant challenge.
Medicines requiring refrigeration, such as biologics and vaccines, are particularly vulnerable to geopolitical disruptions.
Disruptions in energy markets can lead to increased production costs and impact drug availability.
Clinical Implications
Pharmaceutical companies should focus on segmenting supply chains based on product criticality and implementing measures like dual sourcing and increased safety stock.
Conclusion
The ongoing geopolitical instability impacts supply chain strategies within the pharmaceutical industry.
For years, Maria Diaz, now 64, considered herself unstoppable. A devoted grandmother, and self-described adventurer, she built her retirement around staying active and fit, enjoying travel, and caring for her grandkids.
